Project Description

In an age where 80% of the economy is service-based, pharma is also reinventing its model. And as new technologies are enabling untapped insights into the human body, wearables may serve as the foundation of a “beyond the pill” approach to delivering value.This session will explore the future of personalized medicine, and how an unconventional partnership between Pharma and Wearable Tech is disrupting healthcare.

Moderator:

John Nosta, President, NostaLab

Speakers:

Nirav ‘Rav’ Sheth, Director of Market Development, Medical, MC10 Inc.
Michael Cantor, MD, JD, Chief Medical Officer, New England Quality Care Alliance
Dr. James Zackheim, PhD, Vice President & Neupro Patient Solutions Leader, UCB, Inc.